School
School of Pharmacy
Department
Pharmacy Practice
Office Location
19 Foster 419
Worcester
Office Phone Office Phone: 508.373.5660
About
Evan Horton is an associate professor of pharmacy practice at MCPHS. Originally from central Pennsylvania, he earned his Doctor of Pharmacy (PharmD) from Shenandoah University in Winchester, Virginia, in 2005. He completed a PGY1 pharmacy residency at UNM Hospital in Albuquerque, New Mexico, in 2006 and joined the MCPHS faculty later that year.
Dr. Horton is board certified in pediatric pharmacotherapy (BCPPS) and maintains a clinical practice site in general pediatrics at Baystate Medical Center in Springfield, Massachusetts. He is an active member of the Pediatric Pharmacy Association and brings his clinical expertise into the classroom by teaching pediatric pharmacotherapy, pain management, and substance use disorder concepts within the School of Pharmacy.
An expert on pain management and substance use, Dr. Horton has consulted on court cases related to opioids and pain management. He has also delivered national presentations on the heroin epidemic and the education of medical professionals about medical cannabis.
Education
- PharmD, Shenandoah University
- PGY-1 Pharmacy Practice Residency - University of New Mexico Health Sciences Center
Research Interests
- Pediatric Pharmacotherapy
- Medical Cannabis
- Pain Management
Programs
Featured Affiliations
Pediatric Pharmacy Association
WebsiteAmerican Association of Colleges of Pharmacy
WebsiteEducation
- PharmD, Shenandoah University
- PGY-1 Pharmacy Practice Residency - University of New Mexico Health Sciences Center
Research Interests
- Pediatric Pharmacotherapy
- Medical Cannabis
- Pain Management
Programs
Publications
Peer reviewed articles
- Hagmann SHF, Hodle T, Brennan M, Szczerba F, Camelo IY, Beachy J, Horton ER. (2023) Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants. Pediatr Infect Dis J. Oct 27. doi: 10.1097/INF.0000000000004155. Epub ahead of print.
- Kerliu L, Myruski S, Bhatti A, Soni P, Petrosius P, Pervanas HC, Horton ER. (2020) Niraparib for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Ann Pharmacother, online March 20, 2020. journals.sagepub.com/doi/10.1177/1060028020912749
- Klatte JM, Knee A, Szczerba F, Horton ER, Kopcza K, Fisher DJ. (2019). Identification of high-yield targets for antimicrobial stewardship program efforts within a nonfreestanding children’s hospital. Hospital Pediatrics, 9(5):355-64
- Matson KL, Johnson PN, Tran V, Horton ER, Sterner-Allison J, and for the Advocacy Committee on behalf of Pediatric Pharmacy Advocacy Group (2019) Opioid Use in Children. J Pediatr Pharmacol Ther January-February, 24(1):72-75.
- Klatte JM, Kopcza K, Knee , Horton ER, Housman E, and Fisher DJ (2018) Implementation and Impact of an Antimicrobial Stewardship Program at a Non-freestanding Children's Hospital. J Pediatr Pharmacol Ther, 23(2): 84-91.
- Matson KL, Horton ER, Capino AC. (2017). Medication dosage in overweight and obese children. J Pediatr Pharmacol The,. 22(1):81-83.
- Conway SL, Horton ER. (2015). Emergent treatment of status epilepticus in children. US Pharm, 40(5):HS25-31.
- McGann S, Horton ER. (2015). Radium-223 dichloride: a novel treatment option for castration-resistent prostate cancer patients with symptomatic bone metastases. Ann Pharmacother, 49(4), 469-76.
- Horton ER, Morin, A, Pervanas HC, Mukherjee SM, Belliveau P. (2014). A Novel Structured Format for Engaging Pharmacy Students in Bioethics Discussions. Am J Pharm Educ, 78(9), article 171
- Szerszen M, Horton ER. (2014). Infliximab for the treatment of pediatric ulcerative colitis. Eur J Hosp Pharm, 21(6), 361-66.
- Horton ER, Belliveau P. (2014). Pediatric pharmacotherapy in the PharmD curriculum: course design and student self-assessment of learning outcomes achievement. Currents in Pharmacy Teaching and Learning, 6(2), 277-83.
- Pesaturo KA, Horton ER, Belliveau PP. (2012). Inhaled aztreonam lysine for cystic fibrosis pulmonary-related outcomes. Ann Pharmacother, 46(7-8), 1076-85.
- Decelle K, Horton ER. (2012). Tocilizumab for the treatment of juvenile idiopathic arthritis. Ann Pharmacother, 46(6), 822-9.
- Horton ER, Upchurch H, Michelucci A. (2011). Development of a postgraduate year 1 pharmacy residency program at a large teaching hospital. Am J Hosp Pharm, 13, 1245-1250.
- Donovan JL, Kanaan AO, Silva MA, Horton ER, Abel C, Belliveau PP. (2011). Assessment of CAPE outcomes in a capstone course of an accelerated pharmacy program. Currents in Pharmacy Teaching and Learning, 3, 299-306.
- Horton ER. (2008). Adverse Events in Pediatric Sedation. US Pharm, 33(3), HS2-HS8.
- Matthews M, Horton ER. (2007). Managing Central Pain Syndromes. US Pharm, 32(5), HS-20-HS31.
Book chapters
- Cross JE, Horton ER, Yogaratnam D. (2023) Respiratory Tract Infections. In: Zeind CS, ed. Applied Therapeutics: The Clinical Use of Drugs. 12th ed. Philadelphia, PA: Wolters Kluwer; 1458-75
- Cross JE, Horton ER, Yogaratnam D. (2018). Ch. 67: Respiratory tract infections: In: Zeind CS, Carvalho MG Eds. Applied Therapeutics 11th Ed. Wolters-Kluwer:1404-1420.
- Horton ER, Kelly B. (2010-2015). Tourette Syndrome. In: F. Domino, Ed., 5 Minute Clinical Consult, 19th – 23rd Ed. Lippincott, Williams, & Wilkins.
- Pesaturo K, Horton ER, Pelletier A. (2010-2013). Henoch-Schonlein Purpura. In: F. Domino, Ed., 5 Minute Clinical Consult, 19th – 22nd Ed. Lippincott, Williams, & Wilkins.
Awards and Honors
- 2014, MCPHS University Faculty Scholarship Showcase Award (Teaching)
- 2009 Advisor of the Year
- 2013, MCPHS University School of Pharmacy Wor/Man Academic of the Year
- 2010, Pediatric Pharmacy Advocacy Group (PPAG) Award for Best Original Research
- 2009, MCPHS-Worcester Student Government Association Club Advisor of the Year